GUARDO, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 588
Totale 588
Nazione #
IT - Italia 588
Totale 588
Città #
Genova 266
Genoa 136
Rapallo 99
Vado Ligure 83
Bordighera 4
Totale 588
Nome #
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 139
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 127
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 124
Underlying CTLA4 deficiency in a patient with juvenile idiopathic arthritis and autoimmune lymphoproliferative syndrome features successfully treated with abatacept - A case report 55
The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders 51
Genetic screening of children with marrow failure. The role of primary Immunodeficiencies 35
Targeted ngs yields plentiful ultra-rare variants in inborn errors of immunity patients 30
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies 29
Infection risk of Mycophenolate Mofetil and Sirolimus treatments in patients with Autoimmune Cytopenias and Primary Immuno-Regulatory Disorders. 16
Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience 11
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 4
Totale 621
Categoria #
all - tutte 3.120
article - articoli 3.037
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 0 0 14 10 12 12 8 2
2020/202140 2 3 2 1 6 3 0 7 3 4 2 7
2021/202279 1 1 6 7 2 6 2 10 11 16 3 14
2022/2023121 11 16 2 10 18 14 0 2 15 8 21 4
2023/2024113 0 10 2 12 9 11 6 20 7 4 20 12
2024/202595 7 14 6 19 22 25 2 0 0 0 0 0
Totale 621